Torrent Pharmaceuticals Limited (TORNTPHARM)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 consolidated revenue 4,979 Cr (+51%), EBITDA 1,666 Cr (+54%), margin 33.5%
- JB merger integration caused transient revenue impact; JB India branded +7%, international -7%
- Torrent base India business +20%, Brazil +38%, US generics +24%, Germany -7%
- Cost synergies ahead of plan; INR450 Cr target likely achieved by FY28
- R&D spend increased to 4.2% of revenue, sustained for 2-3 years
- Brazil business growing double-digit; 53 molecules under ANVISA review
- US filings increased; 9-10 products expected this fiscal year
- Semaglutide India market share 32%, supply restored after disruption
- IPM growth strong at 12% in H1 FY27, expected to sustain near 10% next year
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 TORNTPHARM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add TORNTPHARM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Torrent Pharmaceuticals Limited
Important.
The summary above is generated automatically from Torrent Pharmaceuticals Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.